1. Rationing of Drugs for Rare Diseases

   • Dyfrig Hughes

   Editorial 09 October 2012 Pages: 315 - 316

2. Bernard S. Bloom, PhD

   • Henry A. Glick

   In Memory 09 October 2012 Pages: 317 - 318

3. The Burden of Age-Related Macular Degeneration

   • Jordana K. Schmier
   • Mechelle L. Jones
   • Michael T. Halpern

   Leading Article 09 October 2012 Pages: 319 - 334

   

4. Economic and Developmental Considerations for Pharmacogenomic Technology

   • John A. Vernon
   • Scott J. Johnson
   • Antonio Trujillo

   Leading Article 09 October 2012 Pages: 335 - 343

   

5. Optimal Assignment of Treatments to Health States Using a Markov Decision Model

   • Mohan V. Bala
   • Josephine A. Mauskopf

   Leading Article 09 October 2012 Pages: 345 - 354

   

6. Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment

   • Zoë Philips
   • Laura Bojke
   • Su Golder

   Review Article 09 October 2012 Pages: 355 - 371

   

7. Post-Exposure Influenza Prophylaxis with Oseltamivir

   • Beate Sander
   • Frederick G. Hayden
   • Louis P. Garrison Jr

   Original Research Article 09 October 2012 Pages: 373 - 386

   

8. A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy

   • Aslam H. Anis
   • Huiying Sun
   • Marc Brisson

   Original Research Article 09 October 2012 Pages: 387 - 400

   

9. Productivity Costs in Health-State Valuations

   • Marieke Krol
   • Werner Brouwer
   • Pedram Sendi

   Original Research Article 09 October 2012 Pages: 401 - 414

   

10. Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women

    • Stephanie Land

    Correspondence 09 October 2012 Pages: 415 - 416

11. The Authors’ Reply

    • Richard J. Milne
    • Kathy H. Heaton-Brown
    • Alison Cubitt

    Correspondence 09 October 2012 Pages: 416 - 417